This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2003 Dec;12(4):347-8.

doi: 10.1046/j.1365-2869.2003.00380.x.

Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy

Michel Lecendreux, Stephanie Maret, Claudio Bassetti, Marie-Christine Mouren, Mehdi Tafti

PMID: 14633248
DOI: 10.1046/j.1365-2869.2003.00380.x

Case Reports

Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy

Michel Lecendreux et al. J Sleep Res. 2003 Dec.

. 2003 Dec;12(4):347-8.

doi: 10.1046/j.1365-2869.2003.00380.x.

Authors

Michel Lecendreux, Stephanie Maret, Claudio Bassetti, Marie-Christine Mouren, Mehdi Tafti

PMID: 14633248
DOI: 10.1046/j.1365-2869.2003.00380.x

No abstract available

PubMed Disclaimer

Similar articles

No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy.
Valko PO, Khatami R, Baumann CR, Bassetti CL. Valko PO, et al. J Neurol. 2008 Dec;255(12):1900-3. doi: 10.1007/s00415-008-0996-2. Epub 2008 Sep 25. J Neurol. 2008. PMID: 18825431
Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset.
Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M. Dauvilliers Y, et al. Ann Neurol. 2004 Dec;56(6):905-8. doi: 10.1002/ana.20339. Ann Neurol. 2004. PMID: 15562415 Clinical Trial.
Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy.
Fronczek R, Verschuuren J, Lammers GJ. Fronczek R, et al. J Neurol. 2007 Nov;254(11):1607-8. doi: 10.1007/s00415-007-0594-8. Epub 2007 Sep 4. J Neurol. 2007. PMID: 17762946 No abstract available.
Molecular genetics and treatment of narcolepsy.
Dauvilliers Y, Tafti M. Dauvilliers Y, et al. Ann Med. 2006;38(4):252-62. doi: 10.1080/07853890500489700. Ann Med. 2006. PMID: 16754256 Review.
[Diagnostic and therapeutic update in narcolepsy].
Santamaria-Cano J. Santamaria-Cano J. Rev Neurol. 2012 May 21;54 Suppl 3:S25-30. Rev Neurol. 2012. PMID: 22605629 Review. Spanish.

See all similar articles

Cited by

Immunotherapy in Narcolepsy.
Giannoccaro MP, Sallemi G, Liguori R, Plazzi G, Pizza F. Giannoccaro MP, et al. Curr Treat Options Neurol. 2020 Jan 30;22(1):2. doi: 10.1007/s11940-020-0609-7. Curr Treat Options Neurol. 2020. PMID: 31997035 Review.
The immunopathogenesis of narcolepsy type 1.
Liblau RS, Latorre D, Kornum BR, Dauvilliers Y, Mignot EJ. Liblau RS, et al. Nat Rev Immunol. 2024 Jan;24(1):33-48. doi: 10.1038/s41577-023-00902-9. Epub 2023 Jul 3. Nat Rev Immunol. 2024. PMID: 37400646 Review.
Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
Knudsen S, Jennum PJ, Alving J, Sheikh SP, Gammeltoft S. Knudsen S, et al. Sleep. 2010 Feb;33(2):169-76. doi: 10.1093/sleep/33.2.169. Sleep. 2010. PMID: 20175400 Free PMC article.
Narcolepsy: current treatment options and future approaches.
Billiard M. Billiard M. Neuropsychiatr Dis Treat. 2008 Jun;4(3):557-66. Neuropsychiatr Dis Treat. 2008. PMID: 18830438 Free PMC article.
Is it Time for Immunotherapy Trials in Narcolepsy?
Lutterotti A. Lutterotti A. J Clin Sleep Med. 2017 Mar 15;13(3):363-364. doi: 10.5664/jcsm.6478. J Clin Sleep Med. 2017. PMID: 28212698 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley